These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy. von Jonquieres G; Spencer ZHT; Rowlands BD; Klugmann CB; Bongers A; Harasta AE; Parley KE; Cederholm J; Teahan O; Pickford R; Delerue F; Ittner LM; Fröhlich D; McLean CA; Don AS; Schneider M; Housley GD; Rae CD; Klugmann M Acta Neuropathol; 2018 Jan; 135(1):95-113. PubMed ID: 29116375 [TBL] [Abstract][Full Text] [Related]
4. In vitro expression of N-acetyl aspartate by oligodendrocytes: implications for proton magnetic resonance spectroscopy signal in vivo. Bhakoo KK; Pearce D J Neurochem; 2000 Jan; 74(1):254-62. PubMed ID: 10617127 [TBL] [Abstract][Full Text] [Related]
5. The cuprizone-induced changes in (1)H-MRS metabolites and oxidative parameters in C57BL/6 mouse brain: Effects of quetiapine. Xuan Y; Yan G; Wu R; Huang Q; Li X; Xu H Neurochem Int; 2015 Nov; 90():185-92. PubMed ID: 26340869 [TBL] [Abstract][Full Text] [Related]
6. Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. Urenjak J; Williams SR; Gadian DG; Noble M J Neurochem; 1992 Jul; 59(1):55-61. PubMed ID: 1613513 [TBL] [Abstract][Full Text] [Related]
7. Renewal of oligodendrocyte lineage reverses dysmyelination and CNS neurodegeneration through corrected N-acetylaspartate metabolism. Lotun A; Li D; Xu H; Su Q; Tuncer S; Sanmiguel J; Mooney M; Baer CE; Ulbrich R; Eyles SJ; Strittmatter L; Hayward LJ; Gessler DJ; Gao G Prog Neurobiol; 2023 Jul; 226():102460. PubMed ID: 37149081 [TBL] [Abstract][Full Text] [Related]
8. Cuprizone-induced demyelination and demyelination-associated inflammation result in different proton magnetic resonance metabolite spectra. Praet J; Orije J; Kara F; Guglielmetti C; Santermans E; Daans J; Hens N; Verhoye M; Berneman Z; Ponsaerts P; Van der Linden A NMR Biomed; 2015 Apr; 28(4):505-13. PubMed ID: 25802215 [TBL] [Abstract][Full Text] [Related]
9. N-Acetylaspartate Synthase Deficiency Corrects the Myelin Phenotype in a Canavan Disease Mouse Model But Does Not Affect Survival Time. Maier H; Wang-Eckhardt L; Hartmann D; Gieselmann V; Eckhardt M J Neurosci; 2015 Oct; 35(43):14501-16. PubMed ID: 26511242 [TBL] [Abstract][Full Text] [Related]
10. Cuprizone-induced graded oligodendrocyte vulnerability is regulated by the transcription factor DNA damage-inducible transcript 3. Fischbach F; Nedelcu J; Leopold P; Zhan J; Clarner T; Nellessen L; Beißel C; van Heuvel Y; Goswami A; Weis J; Denecke B; Schmitz C; Hochstrasser T; Nyamoya S; Victor M; Beyer C; Kipp M Glia; 2019 Feb; 67(2):263-276. PubMed ID: 30511355 [TBL] [Abstract][Full Text] [Related]
11. N-acetylaspartate supports the energetic demands of developmental myelination via oligodendroglial aspartoacylase. Francis JS; Wojtas I; Markov V; Gray SJ; McCown TJ; Samulski RJ; Bilaniuk LT; Wang DJ; De Vivo DC; Janson CG; Leone P Neurobiol Dis; 2016 Dec; 96():323-334. PubMed ID: 27717881 [TBL] [Abstract][Full Text] [Related]
12. N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Moffett JR; Ross B; Arun P; Madhavarao CN; Namboodiri AM Prog Neurobiol; 2007 Feb; 81(2):89-131. PubMed ID: 17275978 [TBL] [Abstract][Full Text] [Related]
13. The Changes in Meknatkhah S; Dashti PS; Raminfard S; Rad HS; Mousavi MS; Riazi GH J Mol Neurosci; 2021 Apr; 71(4):804-809. PubMed ID: 32915417 [TBL] [Abstract][Full Text] [Related]
14. In-vivo proton MR-spectroscopy of the human brain: assessment of N-acetylaspartate (NAA) reduction as a marker for neurodegeneration. Block W; Träber F; Flacke S; Jessen F; Pohl C; Schild H Amino Acids; 2002; 23(1-3):317-23. PubMed ID: 12373553 [TBL] [Abstract][Full Text] [Related]
15. Effects of ethanol and of alcohol dehydrogenase inhibitors on the reduction of N-acetylaspartate levels of brain in mice in vivo: a search for substances that may have therapeutic value in the treatment of Canavan disease. Baslow MH; Suckow RF; Hungund BL J Inherit Metab Dis; 2000 Nov; 23(7):684-92. PubMed ID: 11117430 [TBL] [Abstract][Full Text] [Related]
16. Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study. Simone IL; Tortorella C; Federico F; Liguori M; Lucivero V; Giannini P; Carrara D; Bellacosa A; Livrea P J Neurol Sci; 2001 Jan; 182(2):143-50. PubMed ID: 11137520 [TBL] [Abstract][Full Text] [Related]
17. Short-term cuprizone feeding induces selective amino acid deprivation with concomitant activation of an integrated stress response in oligodendrocytes. Goldberg J; Daniel M; van Heuvel Y; Victor M; Beyer C; Clarner T; Kipp M Cell Mol Neurobiol; 2013 Nov; 33(8):1087-98. PubMed ID: 23979168 [TBL] [Abstract][Full Text] [Related]
18. Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI): An In Vivo Proton Magnetic Resonance Spectroscopy (1H-MRS) Study. Veeramuthu V; Seow P; Narayanan V; Wong JHD; Tan LK; Hernowo AT; Ramli N Acad Radiol; 2018 Sep; 25(9):1167-1177. PubMed ID: 29449141 [TBL] [Abstract][Full Text] [Related]
19. Whole-brain N-acetylaspartate as a surrogate marker of neuronal damage in diffuse neurologic disorders. Rigotti DJ; Inglese M; Gonen O AJNR Am J Neuroradiol; 2007; 28(10):1843-9. PubMed ID: 17921226 [TBL] [Abstract][Full Text] [Related]
20. N-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: a proton magnetic resonance spectroscopy (1H MRS) study. Szulc A; Galińska B; Tarasów E; Kubas B; Dzienis W; Konarzewska B; Poplawska R; Tomczak AA; Czernikiewicz A; Walecki J Med Sci Monit; 2007 May; 13 Suppl 1():17-22. PubMed ID: 17507880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]